WallStSmart

CryoCell International Inc (CCEL)vsFresenius Medical Care Corporation (FMS)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

Fresenius Medical Care Corporation generates 62480% more annual revenue ($19.48B vs $31.13M). FMS leads profitability with a 4.2% profit margin vs -6.3%. FMS appears more attractively valued with a PEG of 0.79. FMS earns a higher WallStSmart Score of 52/100 (C-).

CCEL

Hold

47

out of 100

Grade: D+

Growth: 6.0Profit: 5.0Value: 7.0Quality: 5.5
Piotroski: 6/9Altman Z: -0.53

FMS

Buy

52

out of 100

Grade: C-

Growth: 3.3Profit: 5.0Value: 8.7Quality: 5.5
Piotroski: 6/9Altman Z: 1.96
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CCELUndervalued (+33.5%)

Margin of Safety

+33.5%

Fair Value

$5.02

Current Price

$4.15

$0.87 discount

UndervaluedFair: $5.02Overvalued
FMSUndervalued (+68.8%)

Margin of Safety

+68.8%

Fair Value

$76.99

Current Price

$20.44

$56.55 discount

UndervaluedFair: $76.99Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CCEL3 strengths · Avg: 10.0/10
Return on EquityProfitability
129.2%10/10

Every $100 of equity generates 129 in profit

EPS GrowthGrowth
75.1%10/10

Earnings expanding 75.1% YoY

Debt/EquityHealth
-0.0410/10

Conservative balance sheet, low leverage

FMS3 strengths · Avg: 8.7/10
Price/BookValuation
0.7x10/10

Reasonable price relative to book value

PEG RatioValuation
0.798/10

Growing faster than its price suggests

P/E RatioValuation
13.5x8/10

Attractively priced relative to earnings

Areas to Watch

CCEL4 concerns · Avg: 3.0/10
Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

Market CapQuality
$39.10M3/10

Smaller company, higher risk/reward

Operating MarginProfitability
0.6%3/10

Operating margin of 0.6%

Altman Z-ScoreHealth
-0.532/10

Distress zone — elevated risk

FMS4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
1.1%4/10

1.1% revenue growth

Altman Z-ScoreHealth
1.964/10

Grey zone — moderate risk

Return on EquityProfitability
6.4%3/10

ROE of 6.4% — below average capital efficiency

Profit MarginProfitability
4.2%3/10

4.2% margin — thin

Comparative Analysis Report

WallStSmart Research

Bull Case : CCEL

The strongest argument for CCEL centers on Return on Equity, EPS Growth, Debt/Equity. PEG of 1.34 suggests the stock is reasonably priced for its growth.

Bull Case : FMS

The strongest argument for FMS centers on Price/Book, PEG Ratio, P/E Ratio. PEG of 0.79 suggests the stock is reasonably priced for its growth.

Bear Case : CCEL

The primary concerns for CCEL are Revenue Growth, Market Cap, Operating Margin.

Bear Case : FMS

The primary concerns for FMS are Revenue Growth, Altman Z-Score, Return on Equity. Thin 4.2% margins leave little buffer for downturns.

Key Dynamics to Monitor

CCEL profiles as a turnaround stock while FMS is a value play — different risk/reward profiles.

FMS carries more volatility with a beta of 0.79 — expect wider price swings.

FMS is growing revenue faster at 1.1% — sustainability is the question.

FMS generates stronger free cash flow (560M), providing more financial flexibility.

Bottom Line

FMS scores higher overall (52/100 vs 47/100). CCEL offers better value entry with a 33.5% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

CryoCell International Inc

HEALTHCARE · MEDICAL CARE FACILITIES · USA

Cryo-Cell International, Inc. is dedicated to cell processing and cryogenic cell storage with a focus on collecting and preserving umbilical cord blood stem cells for family use. The company is headquartered in Oldsmar, Florida.

Fresenius Medical Care Corporation

HEALTHCARE · MEDICAL CARE FACILITIES · USA

Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America and internationally. The company is headquartered in Bad Homburg, Germany.

Visit Website →

Want to dig deeper into these stocks?